Lv1
38 积分 2025-09-15 加入
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
20天前
已关闭
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non–Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
20天前
已完结
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
20天前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
20天前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
20天前
已完结
P1.27-09 Efficacy and Safety of Aumolertinib as Adjuvant Therapy in Resectable Stage I NSCLC with High-grade Patterns and EGFR Mutations (APPOINT)
1个月前
已关闭
Complications of total hip arthroplasty
1个月前
已关闭
231P The efficacy of adjuvant EGFR-TKI therapy for stage IA non-small cell lung cancer with EGFR mutations: A retrospective cohort study
1个月前
已关闭
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study
1个月前
已完结
Signal Transduction and Targeted Therapy
2个月前
已关闭
皖公网安备34019202002308
